Figure 2From: Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study Kaplan-Meier plots by CD4 count (μL) among 1257 adults starting antiretroviral therapy (top panel) and haemoglobin (g/mL) levels among 1206 adults starting antiretroviral therapy (bottom panel).Back to article page